ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth
Benchmark: Nifty Pharma TRI · Riskometer: Very High
₹21.0563
NAV (2026-08-31)
₹156.885 Cr
AUM (2026-08-31)
0.52%
EXPENSE RATIO (DIRECT)
2022-11-25
INCEPTION
Punji Fund Health Score - percentile-within-category. See methodology.
CHART
Rolling CAGR by holding period - min, median, max
Each group is one holding-period length. Full range of outcomes across every overlapping window in the fund's history, not one trailing number.
| Metric | Value | Percentile | Category median |
|---|---|---|---|
| 3Y Rolling CAGR | 22.3% | 91.89th | 12.7% |
This fund tracks an index, so measuring alpha against that same index would only report its tracking error.
CHART
Top sector holdings
Share of portfolio (% to NAV) in each of the top sectors.
TOP HOLDINGS
This fund tracks an index, so its behaviour mirrors that index rather than a manager's decisions. Matching it to peers on behaviour would not say anything useful.
CHART
Asset Allocation
As of Jul-2026
CHART
Market Cap Split
As of Jul-2026
Portfolio analytics as of Jul-2026.
Data as of 2026-09-02. Source: AMFI disclosures via Punji. Not investment advice.